Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105566270B reveals Mn-catalyzed route for 3-aryl coumarin derivatives offering high yield and mild conditions for cost-effective pharmaceutical intermediate manufacturing supply chains.
Patent CN115353482B reveals metal-free synthesis for high-purity azaspiro compounds. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel Pd-catalyzed carbonylation method for high-purity benzofuran acetamide intermediates. Reduces cost and simplifies supply chain for pharmaceutical manufacturing.
Novel Pd-catalyzed route for 3-alkynylbenzofuran. High purity, scalable, cost-effective heterocyclic intermediate for pharma.
Novel Pd-catalyzed one-pot method for high-purity trifluoromethyl chromone quinoline intermediates. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN117417339A reveals Rhodium-catalyzed route for trifluoromethyl indoles. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing partners.
Novel Pd-catalyzed carbonylation patent CN115286628B offers efficient synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel Pd-catalyzed method for 2-trifluoromethyl quinazolinones offers high yields and broad substrate scope for efficient drug molecule synthesis.
Patent CN114276280B reveals enzymatic route for chiral sulfonamide. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Discover a novel metal-free synthesis for pyrimidoindazole compounds via patent CN109912606B. Offers cost reduction in API manufacturing and scalable production.
Patent CN103709101B reveals efficient Pictet-Spengler route for renieramycin G intermediates. Enables cost reduction and scalable supply for anticancer drug development projects globally.
Patent CN108047261B reveals a high-yield route for Crisaborole using protected benzyl alcohol intermediates, offering cost-effective API manufacturing solutions.
Novel Rh-catalyzed C-H activation for trifluoromethyl enaminones. High purity, scalable process for pharma intermediates. Reliable supplier for complex synthesis.
Patent CN115215810B reveals catalyst-free heating method. Delivers cost reduction in pharmaceutical intermediates manufacturing and high-purity supply chain reliability.
Novel metal-free pathway enhances purity and supply chain stability for fluorinated heterocyclic pharmaceutical intermediates using accessible raw materials and air atmosphere conditions.
Novel copper-catalyzed route for quinazolinones. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for cost reduction.
Patent CN115286553B reveals nickel-catalyzed carbonylation for indoles. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel one-pot metal-free halogenation and coupling route for quinoline derivatives. Delivers cost reduction in pharma intermediate manufacturing with high purity.
Patent CN117820316B reveals efficient chiral phosphoric acid catalysis. Enables cost reduction and supply chain reliability for anticancer intermediates.
Patent CN117187839A reveals electrocatalytic synthesis of gamma-deuterated pyridines. Offers green, cost-effective solutions for deuterated drug intermediate manufacturing and supply chain stability.